Biology subjects

Gabed, N.

Publications and source records attributed to Gabed, N..

4 recordsLinked to original sources

bioRxiv2026

Loss-of-function phenomics, ncORFs, and ambiguity of mutant phenotypes in Medicago truncatula

Non-canonical open reading frames (ncORFs) are an emerging area of research that is quickly gaining momentum. Many peptides and proteins missed in initial annotation efforts (ncProts) were subsequently shown to be crucial for a wide range of biological processes. The discovery of ncORFs continues to improve the accuracy of loss-of-function studies because they often occupy the same genomic spaces as annotated ORFs. While databases of mutant phenotypes linked to genomic loci exist in a few species, none of these databases integrate the information on ncORFs present in already characterized loci. In this study, we introduce a nearly comprehensive loss-of-function phenomics dataset of Medicago truncatula (673 loci characterized over the past 30 years), which was integrated as a new track into the genome browser of this organism. This dataset helped critically analyze the potential contribution of ncORFs to published phenotypes. We detected mass spectrometry (MS)-validated ncORFs in 10 characterized genes, including major regulators of development and symbiotic relationships. We also found conserved ncORFs in 113 characterized genes, including four genes with highly conserved ncORFs. In some studies, the contribution of these ncORFs can be ruled out, while in others it cannot. Using real examples, we systematized ambiguities associated with ncORFs. Furthermore, we highlighted little-known trans effects of insertional mutagenesis on splicing as contributors to that ambiguity. Finally, our meta-analysis of published phenotypes revealed that different protein classes have significantly different (unique) proportions of unconditional, conditional, and neutral phenotypes, potentially reflecting their relative functional importance. Significance statementThis study is the first to merge a nearly comprehensive inventory of loss-of-function studies in a eukaryotic organism with the information on novel MS-validated and conserved ncORFs.

genetics↗

bioRxiv2025

ShiftSCAN, a program that predicts potential alternative sources of mass spectrometry-derived peptides, improves the accuracy of studies on novel amino acid sequences

Mass spectrometry (MS) proteomics is currently the most powerful tool for identifying both annotated proteins and proteins translated from non-canonical open reading frames or unusual genetic events. With this method, numerous novel protein-coding loci have been discovered by searching for short fragments of hypothetical longer peptides and polypeptides. Apart from the validation of translation from mRNA transcripts, MS proteomics has been instrumental for the detection of peptides encoded by non-mRNA transcripts. A special application field of MS proteomics is studies on programmed ribosomal frameshifting (PRF), where the detection of chimeric peptides produced from two different reading frames is vital. Each novel chimeric peptide is thought to originate from a certain genetic locus. However, due to the short length of MS peptides, there is a possibility that MS-supported chimeric peptides are produced by additional (alternative) loci via PRF. This scenario evaded due attention because the contribution of non-canonical peptides and proteins to the functional diversity of proteomes is still thought to be minor. Recent studies have challenged this paradigm. To the best of our knowledge, our group was the first to include alternative chimeric sources into the analysis pipeline. This resulted in a much higher certainty about loci responsible for the production of unusual peptides. This certainty is crucial for the functional characterization of such loci. At the same time, our study revealed enormous diversity of potential alternative sources for a subset of MS-supported non-canonical peptides. Here, we present a highly flexible program that predicts alternative chimeric and non-chimeric sources of peptides detected by MS proteomics.

bioinformatics↗

bioRxiv2025

A universal pipeline MosaicProt enables large-scale modeling and detection of chimeric protein sequences for studies on programmed ribosomal frameshifting

Peptides and proteins produced by programmed ribosomal frameshifting (PRF) are well-known in viruses. In non-viral systems, only a few examples of such chimeric sequences have been documented until recently. Two new studies, one in humans and one in plants, showed that chimeric peptides are numerous and diverse. In humans, their discovery was possible due to focusing on sequences with naturally repeated codons. This way, many candidate sequences with mass spectrometry (MS) proteomics-based support for translation have been identified. In the plant study, our group discovered MS-validated chimeric peptides using a unique modeling algorithm, which is described and made available here. Our pipeline enables the identification of chimeric peptides in any organism for which transcript sequences and MS proteomic data are available. By design, our approach does not require prior knowledge about sequence similarity to already characterized PRF sites and can detect forward and backward frameshifts by 1 and 2 nucleotides. Thus, our pipeline opens a path for uncovering previously unknown PRF events across various transcript types, potentially broadening our understanding of proteome diversity.

bioinformatics↗

bioRxiv2024

Discovery of diverse chimeric peptides in a eukaryotic proteome sets the stage for the experimental proof of the mosaic translation hypothesis

The high complexity of eukaryotic organisms enabled their evolutionary success, which became possible due to the diversification of eukaryotic proteomes. Various mechanisms contributed to this process. Alternative splicing had the largest known impact among these mechanisms: tens or hundreds of protein isoforms produced from a single genetic locus. Earlier, we hypothesized that along with alternative splicing, a different but conceptually similar mechanism creates novel versions of existing proteins in all eukaryotes. However, this mechanism acts at the level of translation, where the novelty of an amino acid sequence is achieved via multiple programmed ribosomal frameshifting. This mechanism, which is termed mosaic translation, is very difficult to demonstrate even with the most up-to-date molecular tools. Thus, it remained unnoticed so far. Using only a portion of all mass spectrometry proteomic data generated from various organs of the model plant Medicago truncatula, we attempted the first step toward the experimental proof of this hypothesis. Our original in silico approach resulted in the discovery of two candidates for mosaic proteins (homologs of EF1 and RuBisCo) and 154 candidates for chimeric peptides. Chimeric peptides and polypeptides are produced in the course of one ribosomal frameshifting event and may correspond to parts of mosaic proteins. In addition, our analysis reveals the possibility of translation of chimeric peptides from five ribosomal RNA transcripts, ten long non-coding RNA transcripts, and one transfer RNA transcript. These findings are very novel and will be the basis for experimental validation in future studies. In this work, we present multiple lines of indirect evidence that support the validity of our in silico data.

biochemistry↗